The microRNA-200 family-A potential diagnostic marker in hepatocellular carcinoma?

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

MicroRNA-200a and -200b Mediated Hepatocellular Carcinoma Cell Migration Through the Epithelial to Mesenchymal Transition Markers

(2012) Chin-Sheng Hung et al.   ANNALS OF SURGICAL ONCOLOGY

An Overview of Biomarkers for the Diagnosis of Hepatocellular Carcinoma

(2012) Mona Abu El Makarem   Hepatitis Monthly

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition

(2011) Philip A. Gregory et al.   MOLECULAR BIOLOGY OF THE CELL

The Progression of Liver Fibrosis Is Related with Overexpression of the miR-199 and 200 Families

(2011) Yoshiki Murakami et al.   PLoS One

The emerging role of miR-200 family of MicroRNAs in epithelial-mesenchymal transition and cancer metastasis

(2011) Manav Korpal et al.   RNA Biology

New kids on the block: Diagnostic and prognostic microRNAs in hepatocellular carcinoma

(2010) Junfang Ji et al.   CANCER BIOLOGY & THERAPY

The changing pattern of epidemiology in hepatocellular carcinoma

(2010) Helena Nordenstedt et al.   DIGESTIVE AND LIVER DISEASE

Serum Markers of Hepatocellular Carcinoma

(2010) Giulia Malaguarnera et al.   DIGESTIVE DISEASES AND SCIENCES

Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells

(2009) Y. Li et al.   CANCER RESEARCH

miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy

(2009) L. Adam et al.   CLINICAL CANCER RESEARCH

Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated

(2009) Xiao-Hui Huang et al.   HEPATOLOGY RESEARCH

miR-200 Regulates PDGF-D-Mediated Epithelial-Mesenchymal Transition, Adhesion, and Invasion of Prostate Cancer Cells

(2009) Dejuan Kong et al.   STEM CELLS

Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers

(2009) Dawn R. Cochrane et al.   Journal of Oncology

Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applications

(2008) Evi N. Debruyne et al.   CLINICA CHIMICA ACTA

Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival

(2008) J. Jiang et al.   CLINICAL CANCER RESEARCH

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

(2008) S.-M. Park et al.   GENES & DEVELOPMENT

Molecular mechanisms of hepatocellular carcinoma

(2008) Rajagopal N. Aravalli et al.   HEPATOLOGY

Identification of metastasis-related microRNAs in hepatocellular carcinoma

(2008) Anuradha Budhu et al.   HEPATOLOGY

The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional RepressorsZEB1andZEB2

(2008) Manav Korpal et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE